Study of the Safety and Immunogenicity of Catch-up Vaccination With a 21-valent Pneumococcal Conjugate Vaccine (PCV21) in Healthy Infants, Toddlers, Children, and Adolescents
Clinical trial NCT06838000 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06838000
- Sponsor
- Sanofi Pasteur, a Sanofi Company
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-28
- Primary completion
- 2026-12-01
- Enrollment
- 1268
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.